These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33206259)

  • 1. Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.
    Abo El-Ela FI; Hussein KH; El-Banna HA; Gamal A; Rouby S; Menshawy AMS; El-Nahass ES; Anwar S; Zeinhom MMA; Salem HF; Al-Sayed MAY; El-Newery HA; Shokier KAM; El-Nesr KA; Hosein HI
    AAPS PharmSciTech; 2020 Nov; 21(8):326. PubMed ID: 33206259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.
    Abo El-Ela FI; Hussein KH; El-Banna HA; Gamal A; Rouby S; Menshawy AMS; El-Nahass ES; Anwar S; Zeinhom MMA; Salem HF; Al-Sayed MAY; El-Newery HA; Shokier KAM; El-Nesr KA; Hosein HI
    AAPS PharmSciTech; 2020 Dec; 22(1):12. PubMed ID: 33336313
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline.
    Seleem MN; Jain N; Pothayee N; Ranjan A; Riffle JS; Sriranganathan N
    FEMS Microbiol Lett; 2009 May; 294(1):24-31. PubMed ID: 19493005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline-encapsulated solid lipid nanoparticles as promising tool against
    Hosseini SM; Abbasalipourkabir R; Jalilian FA; Asl SS; Farmany A; Roshanaei G; Arabestani MR
    Antimicrob Resist Infect Control; 2019; 8():62. PubMed ID: 30988946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study.
    Hosseini SM; Farmany A; Abbasalipourkabir R; Soleimani Asl S; Nourian A; Arabestani MR
    Ann Clin Microbiol Antimicrob; 2019 Nov; 18(1):33. PubMed ID: 31706304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections.
    Lueth P; Haughney SL; Binnebose AM; Mullis AS; Peroutka-Bigus N; Narasimhan B; Bellaire BH
    J Control Release; 2019 Jan; 294():288-297. PubMed ID: 30572034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano and microparticle drug delivery systems for the treatment of Brucella infections.
    Razei A; Javanbakht M; Hajizade A; Heiat M; Zhao S; Aghamollaei H; Saadati M; Khafaei M; Asadi M; Cegolon L; Keihan AH
    Biomed Pharmacother; 2023 Dec; 169():115875. PubMed ID: 37979375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.
    Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C
    J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
    J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
    Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
    Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Effect of Alginate-chitosan Hydrogel Loaded with Curcumin and Chrysin on Lung and Breast Cancer Cell Lines.
    Abbasalizadeh F; Alizadeh E; Bagher Fazljou SM; Torbati M; Akbarzadeh A
    Curr Drug Deliv; 2022; 19(5):600-613. PubMed ID: 34391378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
    J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
    Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ
    Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice.
    N T; B N; O O; D D; J B
    BMC Complement Altern Med; 2018 May; 18(1):144. PubMed ID: 29724202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.
    Imbuluzqueta E; Gamazo C; Lana H; Campanero MÁ; Salas D; Gil AG; Elizondo E; Ventosa N; Veciana J; Blanco-Prieto MJ
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3326-33. PubMed ID: 23650167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections.
    Domingo S; Gamazo C
    J Chemother; 1996 Feb; 8(1):55-8. PubMed ID: 8835110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Laws TR; Thirlwall RE; MacMillan AP; Brooks TJ; Simpson AJ
    Int J Antimicrob Agents; 2009 Nov; 34(5):471-3. PubMed ID: 19682862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of spontaneous abortion caused by Brucella melitensis biovar 3.
    Yang HX; Feng JJ; Zhang QX; Hao RE; Yao SX; Zhao R; Piao DR; Cui BY; Jiang H
    Infect Dis Poverty; 2018 May; 7(1):31. PubMed ID: 29716658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.